Divis Laboratories Ltd | DIVI - Cash And Equivalent

Stock Price
6,760.50
Daily Change
-161.00 -2.33%
Monthly
7.42%
Yearly
7.66%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR4.15B in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Aurobindo Pharma INR 88.91B 6.56B Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Lupin INR 30.4B 1.02B Sep/2025
Moderna USD 1.91B 687M Mar/2026
Organon & Co USD 1.12B 542M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
Viatris USD 1.8B 481.8M Mar/2026
Xeris Pharmaceuticals USD 111.75M 708K Mar/2026